Altogether, our findings support that the use of metformin and other anti-diabetic drugs capable of crossing the BBB might be promising strategies for the prevention and/or treatment of neurodegenerative diseases characterized by dysregulation of insulin signalling in the brain. The gene discussed is INS; the disease is neurodegenerative disease.